The Quarterly Journal of Nuclear Medicine 1996: Vol 40 Index

3 Pages·1996·0.84 MB·English

Quarterly Journal in English
established in 1957 as Minerva Nucleare THE QUARTERLY JOURNAL OF
the first scientific journal in the world
specifically devoted to Nuclear Medicine NUCLEAR MEDICINE
VOLUME 40 - 1996
Subject Index - Authors’ Index
Subjects Index
A H Peptide receptors radionuclide therapy,
209.
Administration routes, 301. Hepatic tissue, 170. Peptides, 199, 221.
Adrenergic receptors, 108. Hydatidosis, 161 Perfusion imaging, 76.
Adult, 372. Hypothyroidism, 359 PET, 9, 76, 108.
Animal models, 301. Hypoxia, 270 Pharmacokinetics, 202, 221, 270, 285.
Anthracyclin cardiotoxicity, 108. Positron emission tomography, 9, 76, 108.
Anti-peroxidase antibodies, 359. Protein alteration, 176.
Antibodies, 151.
anti-peroxidase, 359. Image fusion, 142.
— engineering, 320. Immunological techniques, 234. R
— monoclonal, 176, 341, 335. Immunoradiometric assay, 182.
Auger electron emitters, 301. Immunoscintigraphy, 9°™Tc-labelling, 161. Radioactivity measurement, 351.
Infant 194. Radioimmunodetection, 335.
Inflammation, 188 Radioimmunotargeting, 320.
B 5-iod o-2’-deoxyuridine, 301 Radionuclide cystography, 372.
Ischemic heart disease, 4 Radiopharmacology, 199, 234, 285.
Biodistribution, 301. Radiotherapy, 285.
Bladder, neurogenic, 372. |? Rats, 351.
Bone radionuclide, imaging, 188. 188Re, 151.
— scintigraphy, 194. Licenses, 27 Reflex, sympathetic dystrophy, 188.
Liver, 170. Renium-188, 151.
Rubidium-82, 76.
Cc M
Cardiac imaging, 142. Magnetic resonance imaging, 132. S
Cardiovascular diseases, 108, 9. Melanoma, 335.
Cerium, 351. Metabolism, 341. Samarium, 351.
Choroid neoplasms, 335. Metaiodobenzylguanidine, 108. Scintigraphy, 170, 301, 359.
Chromatography, 341. MIBG, 108 Single-chain Fv, 320.
Contrast media, 121. Milk, 351. Single photon emission tomography, 108,
Coronary artery diseases, 27, 35, Myocardial imaging, 2 270.
Cytokines, radiolabelled, 290. — functional, 1. Somatostatin analogues, 209.
metabolism, 252. SPECT, 108, 270.
perfusion, 55, 76, 85 Statistics, 35.
— scintigraphy, 35
D
reperfusion, 68.
Diagnosis, 365. viability, 17, 55, 68, 91 T
Diagnostic imaging, 4, 9, 20, 55, 68, 91, 2
Tc, 176, 202, 221, 341.
285, 365. N — adenosine diphosphate, 170.
—- — cardiovascular, 121.
— chelate, 320.
— — myocardial, 252. N-13 ammonia, 76. — labelling, 161.
— tests, 47. Neodymium, 351. Technetium-99m, 170, 176, 202, 221, 320,
Digestive system, 351. Neoplasm therapy, 301. 341.
Direct labeling, 151. Neuropeptides, radiolabeled, 209. Terbium, 351.
DNA, 202. Nuclear cardiology, 17, 47, 7 Thallium radioisotopic, 85.
— pharmacokinetics, 199. 91. Thyroiditis, asymptomatic chronic, 359.
Thyrotropi: , 182.
O — releasin,, ..ormone, 182.
E Tomography, 142.
Octreoscan, 209. Training, 27.
Echocardiography, 91. Octreotide, 209. Tumour imaging, 170.
Electrocardiography, 17. Outcomes, 35.
Epidemiology, 35.
Europium, 351. P U
P280, 221. Ultrasonography, 359.
F P829, 221.
Paraganglioma, 305. Vv
Fatty acids, radioiodinated, 252 Pathophysiology, 188
Fractures, 194. Pentetreotide, 209 Vesicoureteric reflux, 372.
Vol. 40, 1996 THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE
AUTHORS’ INDEX
Authors’ Index
A G M Savi A., 142
Savio E. O., 161, 170.
Adams G. P., 320 Gasparoni P., 359. Maisey M., 47. Schaling D. F., 335.
Adelstein S. J., 301 George A. J. T., 320. Marciniak M., 351. Schwaiger M., 76.
Alazraki P., 85 Giacomini D., 182. Margonato A., 17. Sciagra R., 68.
Atkins H. L., 285 Gilardi M. C., 142. Mariani G., 301. Shirakami Y., 252.
Giordano A., 4. Marmion M., 121. Sloof G. W., 252.
Giubbini R., 27. Maseri A., 4. Srivastava S. C., 285.
B Gonzalez S., 161. Mather S. J., 290. Stafford W. F., 320.
Maurea S., 305. Staudenherz A., 188.
Bakker W. H., 209 Maussier M. L., 182. Stollfuss J. C., 76.
Baltrukiewicz Z., 351 H Maziere B., 108. Strauss H. W., 20.
Beller G. A., 55 McCartney J. E., 320. Stypinski D., 270.
Berman D. S., 35 Hachamovitch R., 35. Merlet P., 108. Sykes T. R., 176, 341.
Bestetti A., 91 Heelan B. T., 320. Morise A. P., 35. Syrota A., 108.
Bisi G., 68. Moyer B. R., 221.
Hnatowich D. J., 151, 202.
Bookman M. A., 320
Hofland L. J., 209.
Borsato N., 359 T
Breeman W. A. P., 209 Hoschl R., 194. N
Britton K. E., 199 Houston L. L., 320.
Huston Jj. S., 320. Nappa A. N., 170.
Tarolo G. L., 91.
Neumann R. D., 365.
Teran M., 161.
Cc Nieto A., 161. Testa A., 182.
Nishimura T., 252.
Trani C., 4.
Campos E. D., 170 I Noujaim A. A., 176, 341. Treves S. T., 372.
Carrozza C., 182
Caussin C., 108 Iskandrian A. S., 27. Oo
Chas J., 351. Vv
Chianelli M., 290 Oppermann H., 320.
Chierchia S. L., 1 J Valenza V., 182.
Chierichetti F., 359 Virzi F., 151.
Chiozzone R. N., 170 Jamar F., 320. YP Visser F. C., 252.
Cuocolo A., 365 Visser Th. J., 209.
Parodi O., 9.
K Pasceri V., 4.
D Pauwels E. K. J., 132, 335. Ww
Kassis A. I., 301. Peng Z., 176, 341.
DErrico G. F. L., Knapp F. F., 252. Peters A. M., 320. Weiner L. M., 320.
De Jong M., 209 Kooij P. Pm., 209. Piot O., 108 Wiebe L. I., 270.
De Roos A., 132 Korpan M., 188. Podio V., 68. Winnard P. Jr., 151.
De Rosa G., 182 Kosa I., 76. Poiseau E., 108. Wolf E. J., 320.
Dean T., 221 Krawczynska E. G., 85. Woo T. K., 341.
DDeiuatmsocnhd E.G,. 1A2.1, 35 KKrreenmneirn gC .,E . 17P0.,. 209. R Wunderbaldinger P.,
Kropp J., 252. Rey A. M., 170.
Kusouka H., 252. Reynolds J. C., 365. x
E
Kwekkeboom D. J., 209. Rizzo G., 142.
Roach J., 194. Xue L. Y., 176, 341
Eisenhut M., 252 Roach P., 372.
L RRootsae bGr.o, ug35h9 . S. F., 234. bs
F
Fazio F., 142 LLeaictahvaa T.C,. J1.8,8 . 170. RRuubseclkloow sDk.i, 3M5.9,. 151. Yamamichi Y., 252.
Ferlin G., 359. Leon A., 161, 170.
Fialka V., 188 Leon Cabana E., 161. S Z
Fiorentini C., 91 Leon E. T., 170.
Fogarasi M., 151 Lister-James J., 221. Salvatore M., 365. Zanco P., 359.
Franken P. R., 252 Lucignani G., 1. Sambuceti G., 9. Ziegler S., 76.
THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE Vol. 40, 1996